vs
爱齐科技（ALGN）与COMMUNITY HEALTH SYSTEMS INC（CYH）财务数据对比。点击上方公司名可切换其他公司
COMMUNITY HEALTH SYSTEMS INC的季度营收约是爱齐科技的3.0倍（$3.1B vs $1.0B）。爱齐科技净利率更高（13.0% vs 3.5%，领先9.4%）。爱齐科技同比增速更快（5.3% vs -4.8%）。爱齐科技自由现金流更多（$187.3M vs $172.0M）。过去两年爱齐科技的营收复合增速更高（2.5% vs -0.5%）
爱齐科技是一家全球知名医疗设备企业，主营设计、生产及销售隐适美透明矫治器、iTero口内扫描仪及配套服务，客户覆盖正畸医师、全科牙医，面向修复、美容牙科领域，业务分为透明矫治器、扫描仪及服务两大板块，可满足青少年等不同群体的正畸需求
社区卫生系统公司总部位于美国田纳西州富兰克林，是财富500强企业。按急症护理机构数量计算，该公司曾是美国最大的综合医院医疗服务提供商。2014年它旗下有约200家医院，到2021年机构数量缩减至约85家。
ALGN vs CYH — 直观对比
营收规模更大
CYH
是对方的3.0倍
$1.0B
营收增速更快
ALGN
高出10.1%
-4.8%
净利率更高
ALGN
高出9.4%
3.5%
自由现金流更多
ALGN
多$15.3M
$172.0M
两年增速更快
ALGN
近两年复合增速
-0.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $3.1B |
| 净利润 | $135.8M | $110.0M |
| 毛利率 | 65.3% | 85.6% |
| 营业利润率 | 14.8% | 14.5% |
| 净利率 | 13.0% | 3.5% |
| 营收同比 | 5.3% | -4.8% |
| 净利润同比 | 30.8% | 254.9% |
| 每股收益（稀释后） | $1.88 | $0.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALGNCYH
| Q4 25 | $1.0B | $3.1B | ||
| Q3 25 | $995.7M | $3.1B | ||
| Q2 25 | $1.0B | $3.1B | ||
| Q1 25 | $979.3M | $3.2B | ||
| Q4 24 | $995.2M | $3.3B | ||
| Q3 24 | $977.9M | $3.1B | ||
| Q2 24 | $1.0B | $3.1B | ||
| Q1 24 | $997.4M | $3.1B |
净利润ALGNCYH
| Q4 25 | $135.8M | $110.0M | ||
| Q3 25 | $56.8M | $130.0M | ||
| Q2 25 | $124.6M | $282.0M | ||
| Q1 25 | $93.2M | $-13.0M | ||
| Q4 24 | $103.8M | $-71.0M | ||
| Q3 24 | $116.0M | $-391.0M | ||
| Q2 24 | $96.6M | $-13.0M | ||
| Q1 24 | $105.0M | $-41.0M |
毛利率ALGNCYH
| Q4 25 | 65.3% | 85.6% | ||
| Q3 25 | 64.2% | 85.1% | ||
| Q2 25 | 69.9% | 85.0% | ||
| Q1 25 | 69.5% | 84.5% | ||
| Q4 24 | 70.0% | 84.5% | ||
| Q3 24 | 69.7% | 84.8% | ||
| Q2 24 | 70.3% | 84.6% | ||
| Q1 24 | 70.0% | 84.5% |
营业利润率ALGNCYH
| Q4 25 | 14.8% | 14.5% | ||
| Q3 25 | 9.7% | 7.9% | ||
| Q2 25 | 16.1% | 16.3% | ||
| Q1 25 | 13.4% | 9.0% | ||
| Q4 24 | 14.5% | 8.5% | ||
| Q3 24 | 16.6% | -6.6% | ||
| Q2 24 | 14.3% | 7.6% | ||
| Q1 24 | 15.5% | 7.4% |
净利率ALGNCYH
| Q4 25 | 13.0% | 3.5% | ||
| Q3 25 | 5.7% | 4.2% | ||
| Q2 25 | 12.3% | 9.0% | ||
| Q1 25 | 9.5% | -0.4% | ||
| Q4 24 | 10.4% | -2.2% | ||
| Q3 24 | 11.9% | -12.7% | ||
| Q2 24 | 9.4% | -0.4% | ||
| Q1 24 | 10.5% | -1.3% |
每股收益（稀释后）ALGNCYH
| Q4 25 | $1.88 | $0.82 | ||
| Q3 25 | $0.78 | $0.96 | ||
| Q2 25 | $1.72 | $2.09 | ||
| Q1 25 | $1.27 | $-0.10 | ||
| Q4 24 | $1.40 | $-0.53 | ||
| Q3 24 | $1.55 | $-2.95 | ||
| Q2 24 | $1.28 | $-0.10 | ||
| Q1 24 | $1.39 | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $260.0M |
| 总债务越低越好 | — | $10.4B |
| 股东权益账面价值 | $4.0B | $-1.4B |
| 总资产 | $6.2B | $13.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALGNCYH
| Q4 25 | $1.1B | $260.0M | ||
| Q3 25 | $1.0B | $123.0M | ||
| Q2 25 | $901.2M | $456.0M | ||
| Q1 25 | $873.0M | $431.0M | ||
| Q4 24 | $1.0B | $37.0M | ||
| Q3 24 | $1.0B | $33.0M | ||
| Q2 24 | $761.4M | $39.0M | ||
| Q1 24 | $865.8M | $48.0M |
总债务ALGNCYH
| Q4 25 | — | $10.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $11.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALGNCYH
| Q4 25 | $4.0B | $-1.4B | ||
| Q3 25 | $4.0B | $-1.5B | ||
| Q2 25 | $3.9B | $-1.6B | ||
| Q1 25 | $3.8B | $-1.9B | ||
| Q4 24 | $3.9B | $-1.9B | ||
| Q3 24 | $3.9B | $-1.8B | ||
| Q2 24 | $3.8B | $-1.4B | ||
| Q1 24 | $3.8B | $-1.4B |
总资产ALGNCYH
| Q4 25 | $6.2B | $13.2B | ||
| Q3 25 | $6.2B | $13.2B | ||
| Q2 25 | $6.2B | $13.6B | ||
| Q1 25 | $6.1B | $13.9B | ||
| Q4 24 | $6.2B | $14.1B | ||
| Q3 24 | $6.4B | $13.9B | ||
| Q2 24 | $6.2B | $14.4B | ||
| Q1 24 | $6.2B | $14.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $223.2M | $266.0M |
| 自由现金流经营现金流 - 资本支出 | $187.3M | $172.0M |
| 自由现金流率自由现金流/营收 | 17.9% | 5.5% |
| 资本支出强度资本支出/营收 | 3.4% | 3.0% |
| 现金转化率经营现金流/净利润 | 1.64× | 2.42× |
| 过去12个月自由现金流最近4个季度 | $490.8M | $208.0M |
8季度趋势，按日历期对齐
经营现金流ALGNCYH
| Q4 25 | $223.2M | $266.0M | ||
| Q3 25 | $188.7M | $69.0M | ||
| Q2 25 | $128.7M | $88.0M | ||
| Q1 25 | $52.7M | $120.0M | ||
| Q4 24 | $286.1M | $216.0M | ||
| Q3 24 | $263.7M | $67.0M | ||
| Q2 24 | $159.8M | $101.0M | ||
| Q1 24 | $28.7M | $96.0M |
自由现金流ALGNCYH
| Q4 25 | $187.3M | $172.0M | ||
| Q3 25 | $169.0M | $4.0M | ||
| Q2 25 | $107.2M | $-3.0M | ||
| Q1 25 | $27.4M | $35.0M | ||
| Q4 24 | $263.1M | $107.0M | ||
| Q3 24 | $233.9M | $-3.0M | ||
| Q2 24 | $106.4M | $13.0M | ||
| Q1 24 | $19.3M | $3.0M |
自由现金流率ALGNCYH
| Q4 25 | 17.9% | 5.5% | ||
| Q3 25 | 17.0% | 0.1% | ||
| Q2 25 | 10.6% | -0.1% | ||
| Q1 25 | 2.8% | 1.1% | ||
| Q4 24 | 26.4% | 3.3% | ||
| Q3 24 | 23.9% | -0.1% | ||
| Q2 24 | 10.3% | 0.4% | ||
| Q1 24 | 1.9% | 0.1% |
资本支出强度ALGNCYH
| Q4 25 | 3.4% | 3.0% | ||
| Q3 25 | 2.0% | 2.1% | ||
| Q2 25 | 2.1% | 2.9% | ||
| Q1 25 | 2.6% | 2.7% | ||
| Q4 24 | 2.3% | 3.3% | ||
| Q3 24 | 3.0% | 2.3% | ||
| Q2 24 | 5.2% | 2.8% | ||
| Q1 24 | 0.9% | 3.0% |
现金转化率ALGNCYH
| Q4 25 | 1.64× | 2.42× | ||
| Q3 25 | 3.33× | 0.53× | ||
| Q2 25 | 1.03× | 0.31× | ||
| Q1 25 | 0.57× | — | ||
| Q4 24 | 2.76× | — | ||
| Q3 24 | 2.27× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 0.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALGN
暂无分部数据
CYH
| Managed Care And Other Third Party Payors | $1.5B | 49% |
| Medicare Managed Care | $570.0M | 18% |
| Medicare | $512.0M | 16% |
| Medicaid | $464.0M | 15% |
| Self Pay Revenue | $34.0M | 1% |
